Literature DB >> 12923533

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.

Sagrario Ortega1, Ignacio Prieto, Junko Odajima, Alberto Martín, Pierre Dubus, Rocio Sotillo, Jose Luis Barbero, Marcos Malumbres, Mariano Barbacid.   

Abstract

We targeted the locus encoding the cyclin-dependent kinase 2 (CDK2) by homologous recombination in mouse embryonic stem (ES) cells. Embryonic fibroblasts lacking CDK2 proliferate normally and become immortal after continuous passage in culture. Elimination of a conditional Cdk2 allele in immortal cells does not have a significant effect on proliferation. Cdk2-/- mice are viable and survive for up to two years, indicating that CDK2 is also dispensable for proliferation and survival of most cell types. But CDK2 is essential for completion of prophase I during meiotic cell division in male and female germ cells, an unforeseen role for this cell cycle kinase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923533     DOI: 10.1038/ng1232

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  297 in total

1.  Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies.

Authors:  Glen J Weiss; Manuel Hidalgo; Mitesh J Borad; Daniel Laheru; Raoul Tibes; Ramesh K Ramanathan; Lisa Blaydorn; Gayle Jameson; Antonio Jimeno; Jeffrey D Isaacs; Angela Scaburri; Maria Adele Pacciarini; Francesco Fiorentini; Marina Ciomei; Daniel D Von Hoff
Journal:  Invest New Drugs       Date:  2011-12-09       Impact factor: 3.850

Review 2.  Function of the A-type cyclins during gametogenesis and early embryogenesis.

Authors:  Debra J Wolgemuth
Journal:  Results Probl Cell Differ       Date:  2011

3.  Meiotic errors activate checkpoints that improve gamete quality without triggering apoptosis in male germ cells.

Authors:  Aimee Jaramillo-Lambert; Yuriko Harigaya; Jeffrey Vitt; Anne Villeneuve; JoAnne Engebrecht
Journal:  Curr Biol       Date:  2010-10-21       Impact factor: 10.834

4.  A CDC45 homolog in Arabidopsis is essential for meiosis, as shown by RNA interference-induced gene silencing.

Authors:  Rebecca Stevens; Mathilde Grelon; Daniel Vezon; Jaesung Oh; Peter Meyer; Claudette Perennes; Severine Domenichini; Catherine Bergounioux
Journal:  Plant Cell       Date:  2003-12-05       Impact factor: 11.277

5.  RB reversibly inhibits DNA replication via two temporally distinct mechanisms.

Authors:  Steven P Angus; Christopher N Mayhew; David A Solomon; Wesley A Braden; Michael P Markey; Yukiko Okuno; M Cristina Cardoso; David M Gilbert; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

6.  Intra-S-phase checkpoint activation by direct CDK2 inhibition.

Authors:  Yonghong Zhu; Carmen Alvarez; Ronald Doll; Hirokazu Kurata; Xiao Min Schebye; David Parry; Emma Lees
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 7.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells.

Authors:  Tiziana Parisi; Andreas R Beck; Nathalie Rougier; Tom McNeil; Linda Lucian; Zena Werb; Bruno Amati
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

9.  Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.

Authors:  Lisa K Pierson-Mullany; Carol A Lange
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.

Authors:  Haksier Ehedego; Antje Mohs; Bettina Jansen; Kanishka Hiththetiya; Piotr Sicinski; Christian Liedtke; Christian Trautwein
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.